Difule: Long-termism casts brand value | Invited to share at the Big Health Summit

Difule: Long-termism casts brand value | Invited to share at the Big Health Summit

On March 23, the “Great Health Development Conference” was successfully held at Hi-Creation Week! This conference, together with industry leaders, focuses on key categories of big health such as dairy products and nutrition products, explores new needs in the trend track, and communicates with all maternal and infant colleagues Explore the possibility of industry growth together.

At the Hi-Creation Week exhibition site, Mr. Shen Yang, managing director of Difule Biology, delivered a speech on “Casting Brand Value with Long-termism”, sharing that Difule attaches great importance to micro-ecological health management, human symbiotic microorganisms, and the high value around real needs. Value goals, put forward optimal solutions, and immediately launch pragmatic scientific exploration actions, which is also Difule’s long-term thinking.

What is long-termism? Mr. Shen Yang believes that short-termism pays more attention to the current market preferences. In a market with primary development, short-termism is more flexible and more likely to be welcomed by the market; while long-termism is often the result of problem description. From the current point of view, there will be situations that are not understood, but even so, long-termists will still maintain a stable thinking logic and focus on the optimal solution.

In the game of the market, long-termists and short-termists. The market raises demand, establishes rules, introduces competition, and crowds out short-termists who are chasing short-term interests through cost increases. Long-termists focus on optimal solutions to market demand, digest cost and risk factors through independent pricing power and long-term amortization strategies, and establish long-term competitive advantages.

A mature market requires long-termism to bring the best solutions, and long-termism requires rules and protection brought about by a mature market.

Long-termism is born to solve problems, so every brand that pursues long-termism must have a “problem” that it regards as its brand mission. This is usually a high value problem (High value problem, HVP), which is both the starting point and the end point of the brand. A long-term brand should be born for this and work hard for it.

Optimized solutions to high-value problems (OS-HVP) are the true value of the brand, and the process of exploring this optimized solution is the process of casting brand value.

And Difule is interpreting long-termism with actions.

The high-value problem of Difule, that is, the mission of Difule, is to “reduce the occurrence of diseases, get rid of drug dependence, and reduce medical expenses through efficient microecological health solutions.” Mr. Shen Yang said in his speech.

In order to better understand this mission, Mr. Shen Yang introduced the close relationship between microorganisms, symbiotic microorganisms and human health.

The microbial system is the oldest biological system on this planet. It appeared in the deep sea 3.7 billion years ago. In the long evolution, it has become the symbiotic microorganisms of human beings. It is also a powerful organ of human beings, a super organism that helps us digest food. , boost metabolism, help fight off pathogens, and shape our behavior.

However, with the large-scale use of antibiotics and killing drugs, the diversity of human symbiotic microorganisms is decreasing, and various diseases caused by microecological imbalances have begun to appear, such as high blood pressure, diabetes, heart problems, obesity, asthma, allergies and immunity. And other problems, and these antibiotics and chemical drugs, which have been placed high hopes, are obviously unable to deal with such a dilemma.

In Mr. Shen Yang’s view, human beings need to reconstruct symbiotic microbial organs, activate the potential of the immune system, and establish a new, safe and sustainable health management method to manage our health. This demand is the starting point of Difule, and Difule was born for this.

An optimal solution:

As a microbial exploration technology company that faces future health management methods, Difule is thinking about creating an executable optimization solution to reconstruct the symbiotic micro-ecosystem of the human body. This solution is called the HSMES system.

Through this system, it is possible to monitor the microbial indicators in individuals and the shared environment, and adjust the distribution and density of microorganisms in time, so that the symbiotic micro-ecological environment of humans can establish a high-quality balance and help humans obtain health. This system is most likely to be the first to be used in the living environment of newborns or the living environment of the elderly.

To some extent, the drop-type probiotics that people use today are the early prototype of this system solution idea. In the future, Difule will provide more complex and powerful strain combinations for HSMES systems.

In order to promote this huge scientific research and exploration action, Difule’s long-term vision began to enter the practical work.

▶ Clinical research field

In 2012, Difule established its own transnational, interdisciplinary micro-ecological health clinical research and academic exchange platform MIHC Lab. In just three years since the epidemic, it has published a total of 10 SCI articles and 1 Chinese core journal, of which 2 clinical studies and 8 animal studies. There are a total of 21 clinical trials of probiotics in progress, many of which have achieved exciting results. In the 55th ESPGHAN Academic Annual Conference held in Vienna, Austria in May this year, Difule’s scientific research team will have three academic The report was presented at the meeting. In Mr. Shen Yang’s view, this is not only the achievement of Difule, but also the research strength of China’s local symbiotic microorganisms.

▶ Basic research fields

In 2020, Dipro completed the construction of the P2-enhanced Dipro Microbial Immuno-Metabolism Laboratory (DIPRO MIM LAB), which is a scientific research institution completely independently constructed and wholly owned by Dipro, which means that Dipro has owned The autonomy of basic scientific research on micro-ecological health also has the right to compete with multinational micro-ecological companies for the dominance of China’s localized symbiotic microbial research.

▶Strain preparation field

In 2022, Difule completed the first phase of the scientific research plan of the native probiotic strain bank of the Chinese population, collecting, separating, identifying and storing nearly 10,000 native Chinese, high-quality, native probiotic strains. Difule’s native probiotic strain library plan for Chinese population is a rescue scientific research action for the protection of native strains in China. Every day, 100 original ecological villages in China are disappearing, and those that are important to human health will disappear with them. The collection of high-quality probiotic strains is imminent. According to the progress of such scientific research, Difule will soon have the largest native probiotic strain library in the country.

▶Digital field

In 2022, Difule already has a digital model library of the core flora of infants and young children covering information on the flora of infants and young children in different health states, and has independently developed an AI algorithm and system for the intestinal type and intestinal microecological age of infants and young children. Based on this The results of the research carried out will have wider applicability and validity.

As a beneficiary of the great era of China’s infant and child industry, Difule has already made a choice at the starting point. Although long-termism is scarce, there are still people who stick to it alone; although the road to scientific research is difficult, there are still people who are persistently moving forward. Difule’s choice is always clear and firm.

(Source: New Vision)

Editor in charge: Sun Qingyang